Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.
2.

Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rotschafer JC, Rodvold KA, Maples HD, Lomaestro BM.

Am J Health Syst Pharm. 2020 Mar 19. pii: zxaa036. doi: 10.1093/ajhp/zxaa036. [Epub ahead of print] No abstract available.

PMID:
32191793
3.

Assessment of Time to Clinical Response in Patients with Sepsis Treated Before and After Implementation of a Matrix-Assisted Laser Desorption Ionization Time-of-Flight Blood Culture Identification Algorithm.

Carreno JJ, Lomaestro BM, Jacobs AL, Meyer RE, Evans A, Montero CI.

Infect Control Hosp Epidemiol. 2016 Aug;37(8):916-23. doi: 10.1017/ice.2016.105. Epub 2016 Jun 9. Erratum in: Infect Control Hosp Epidemiol. 2016 Sep;37(9):1134.

PMID:
27277136
4.

MenHibrix: a new combination meningococcal vaccine for infants and toddlers.

Hale SF, Camaione L, Lomaestro BM.

Ann Pharmacother. 2014 Mar;48(3):404-11. doi: 10.1177/1060028013514375. Epub 2013 Dec 18. Review.

PMID:
24353263
5.

Population pharmacokinetics of extended-infusion piperacillin-tazobactam in hospitalized patients with nosocomial infections.

Felton TW, Hope WW, Lomaestro BM, Butterfield JM, Kwa AL, Drusano GL, Lodise TP.

Antimicrob Agents Chemother. 2012 Aug;56(8):4087-94. doi: 10.1128/AAC.00521-12. Epub 2012 May 14.

6.

Vancomycin dosing and monitoring 2 years after the guidelines.

Lomaestro BM.

Expert Rev Anti Infect Ther. 2011 Jun;9(6):657-67. doi: 10.1586/eri.11.46. Review.

PMID:
21692671
7.
8.

Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.

Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL.

Clin Infect Dis. 2009 Aug 15;49(4):507-14. doi: 10.1086/600884.

PMID:
19586413
9.

Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC, Craig WA, Billeter M, Dalovisio JR, Levine DP.

Clin Infect Dis. 2009 Aug 1;49(3):325-7. doi: 10.1086/600877. Erratum in: Clin Infect Dis. 2009 Nov 1;49(9):1465.

PMID:
19569969
10.

Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin.

Lodise TP, Graves J, Evans A, Graffunder E, Helmecke M, Lomaestro BM, Stellrecht K.

Antimicrob Agents Chemother. 2008 Sep;52(9):3315-20. doi: 10.1128/AAC.00113-08. Epub 2008 Jun 30.

11.

Update on the pharmacotherapy of obesity. 1998.

Cerulli J, Lomaestro BM, Malone M.

Ann Pharmacother. 2007 Sep;41(9):1505-17. Epub 2007 Aug 14. Review. No abstract available.

PMID:
17698892
12.

Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists.

Lodise TP, Lomaestro BM, Drusano GL; Society of Infectious Diseases Pharmacists.

Pharmacotherapy. 2006 Sep;26(9):1320-32. Review.

PMID:
16945055
13.

The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York.

Lomaestro BM, Tobin EH, Shang W, Gootz T.

Clin Infect Dis. 2006 Aug 1;43(3):e26-8. Epub 2006 Jun 19.

PMID:
16804837
14.
15.

Resistance to linezolid. Are we surprised? How hard should we look?

Lomaestro BM.

Ann Pharmacother. 2003 Jun;37(6):909-11. Review. No abstract available.

PMID:
12773084
17.

Bioterrorism: pivotal clinical issues. Consensus review of the Society of Infectious Diseases Pharmacists.

Terriff CM, Schwartz MD, Lomaestro BM; Society of Infectious Diseases Pharmacists.

Pharmacotherapy. 2003 Mar;23(3):274-90. Review.

PMID:
12627924
18.

Therapeutic interchange of fluoroquinolones at a medical center.

Lomaestro BM.

Am J Health Syst Pharm. 2001 May 15;58(10):904-7. No abstract available.

PMID:
11381495
19.

Fluoroquinolone-induced renal failure.

Lomaestro BM.

Drug Saf. 2000 Jun;22(6):479-85. Review.

PMID:
10877041
20.

Streptogramins and their potential role in geriatric medicine.

Lomaestro BM, Briceland LL.

Drugs Aging. 1998 Dec;13(6):443-65. Review.

PMID:
9883400
21.

Update on drug interactions with azole antifungal agents.

Lomaestro BM, Piatek MA.

Ann Pharmacother. 1998 Sep;32(9):915-28. Review.

PMID:
9762380
22.

Update on the pharmacotherapy of obesity.

Cerulli J, Lomaestro BM, Malone M.

Ann Pharmacother. 1998 Jan;32(1):88-102. Review.

PMID:
9475827
23.

Medication-prescribing errors in a teaching hospital. A 9-year experience.

Lesar TS, Lomaestro BM, Pohl H.

Arch Intern Med. 1997 Jul 28;157(14):1569-76.

PMID:
9236558
24.

Quinupristin-dalfopristin (RP 59500): an injectable streptogramin combination.

Griswold MW, Lomaestro BM, Briceland LL.

Am J Health Syst Pharm. 1996 Sep 1;53(17):2045-53.

PMID:
8870891
25.

Glutathione in health and disease: pharmacotherapeutic issues.

Lomaestro BM, Malone M.

Ann Pharmacother. 1995 Dec;29(12):1263-73. Review.

PMID:
8672832
26.

Dosing adjustment of 10 antimicrobials for patients with renal impairment.

Preston SL, Briceland LL, Lomaestro BM, Lesar TS, Bailie GR, Drusano GL.

Ann Pharmacother. 1995 Dec;29(12):1202-7.

PMID:
8672821
27.

Absorption interactions with fluoroquinolones. 1995 update.

Lomaestro BM, Bailie GR.

Drug Saf. 1995 May;12(5):314-33. Review.

PMID:
7669261
28.

More on the GUSTO Trial.

Lomaestro BM.

Ann Intern Med. 1994 Nov 15;121(10):818-9. No abstract available.

PMID:
7944069
29.

Continuing problem of ciprofloxacin administered with interacting drugs.

Lomaestro BM, Lesar TS.

Am J Hosp Pharm. 1994 Mar 15;51(6):832. No abstract available.

PMID:
8010328
30.

Effect of multiple staggered doses of calcium on the bioavailability of ciprofloxacin.

Lomaestro BM, Bailie GR.

Ann Pharmacother. 1993 Nov;27(11):1325-8.

PMID:
8286801
31.

Timeliness of medication administration in hemodialysis inpatients: drug use evaluation.

Lomaestro BM, Bailie GR, Eisele G.

Hosp Pharm. 1993 Oct;28(10):980-2, 984.

PMID:
10129141
32.

Pleurodesis with solution prepared from quinacrine hydrochloride tablets.

Lomaestro BM, Lesar TS, Kaslovsky RA.

Clin Pharm. 1993 Sep;12(9):693-5. No abstract available.

PMID:
8306569
33.

Errors in prescribing methotrexate.

Lomaestro BM, Lesar TS, Hager TP.

JAMA. 1992 Oct 21;268(15):2031-2. No abstract available.

PMID:
1404735
34.

Quinolone-cation interactions: a review.

Lomaestro BM, Bailie GR.

DICP. 1991 Nov;25(11):1249-58. Review.

PMID:
1763542
35.

Effect of staggered dose of calcium on the bioavailability of ciprofloxacin.

Lomaestro BM, Bailie GR.

Antimicrob Agents Chemother. 1991 May;35(5):1004-7.

36.

Tissue plasminogen activator and heparin dosage.

Lomaestro BM.

Ann Intern Med. 1990 Apr 1;112(7):549. No abstract available.

PMID:
2107782
37.

Concurrent administration of ciprofloxacin and potentially interacting drugs.

Lomaestro BM, Lesar TS.

Am J Hosp Pharm. 1989 Sep;46(9):1770. No abstract available.

PMID:
2801707
38.

Streamlining antimicrobial therapy through pharmacists' review of order sheets.

Briceland LL, Lesar TS, Lomaestro BM, Lombardi TP, Gailey RA, Kowalsky SF.

Am J Hosp Pharm. 1989 Jul;46(7):1376-80.

PMID:
2757043
39.

Ethylene glycol toxicity--misinterpretation of laboratory data.

Lomaestro BM.

Drug Intell Clin Pharm. 1988 Nov;22(11):915-6. No abstract available.

PMID:
3234263

Supplemental Content

Loading ...
Support Center